Elevation Wealth Partners’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3
Closed -$50 – 492
2025
Q1
$50 Hold
3
– – ﹤0.01% 477
2024
Q4
$65 Buy
+3
New +$58 ﹤0.01% 482

Other funds holding KRSA

Elevation Wealth Partners's KRSA Position: Q2 2025 in Review

Elevation Wealth Partners sold out of Korsana Biosciences (KRSA) in Q2 2025, closing a stake of 3 shares — an estimated $50 sold.

Elevation Wealth Partners first reported a position in KRSA in Q4 2024 and held it in 2 quarters. The position peaked at $65 in Q4 2024. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2025.

  • Elevation Wealth Partners reported no remaining Korsana Biosciences position as of Q2 2025 after selling out during the quarter.
  • Elevation Wealth Partners sold 3 Korsana Biosciences shares in Q2 2025, an estimated $50.
  • Elevation Wealth Partners first reported a position in Korsana Biosciences in Q4 2024 and held it in 2 quarters.
  • Elevation Wealth Partners's Korsana Biosciences position peaked at $65 in Q4 2024.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2025.

Based on Elevation Wealth Partners's 13F filing for Q2 2025, filed 8 Jul 2025.